Explore

Trendline Trendline
MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial

MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial

MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial
Trendline Trendline
Merck's TroFuse-005 Trial Achieves Key Endpoints in Advanced Endometrial Cancer Treatment

Merck's TroFuse-005 Trial Achieves Key Endpoints in Advanced Endometrial Cancer Treatment

Merck's TroFuse-005 Trial Achieves Key Endpoints in Advanced Endometrial Cancer Treatment
Trendline Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Trendline Trendline
Lantern Pharma's LP-300 Trial for Never-Smokers with NSCLC Advances with FDA Support

Lantern Pharma's LP-300 Trial for Never-Smokers with NSCLC Advances with FDA Support

Lantern Pharma's LP-300 Trial for Never-Smokers with NSCLC Advances with FDA Support
Trendline Trendline
Revolution Medicines' Pancreatic Cancer Drug Poised for FDA Approval, Analysts Predict Major Impact

Revolution Medicines' Pancreatic Cancer Drug Poised for FDA Approval, Analysts Predict Major Impact

Revolution Medicines' Pancreatic Cancer Drug Poised for FDA Approval, Analysts Predict Major Impact
Trendline Trendline
CEL-SCI Reports Progress in Multikine Cancer Therapy Development

CEL-SCI Reports Progress in Multikine Cancer Therapy Development

CEL-SCI Reports Progress in Multikine Cancer Therapy Development
Trendline Trendline
Prokarium's ZH9 Shows Promising Results in Bladder Cancer Trial

Prokarium's ZH9 Shows Promising Results in Bladder Cancer Trial

Prokarium's ZH9 Shows Promising Results in Bladder Cancer Trial
Trendline Trendline
FDA Grants Priority Review for Bayer's HYRNUO in Treating HER2-Mutated Lung Cancer

FDA Grants Priority Review for Bayer's HYRNUO in Treating HER2-Mutated Lung Cancer

FDA Grants Priority Review for Bayer's HYRNUO in Treating HER2-Mutated Lung Cancer
Trendline Trendline
Bristol Myers Squibb Expands Oncology Pipeline with Lonza Licensing Agreement

Bristol Myers Squibb Expands Oncology Pipeline with Lonza Licensing Agreement

Bristol Myers Squibb Expands Oncology Pipeline with Lonza Licensing Agreement
Trendline Trendline
Merck's Sacituzumab Tirumotecan Shows Promise in Endometrial Cancer Trial

Merck's Sacituzumab Tirumotecan Shows Promise in Endometrial Cancer Trial

Merck's Sacituzumab Tirumotecan Shows Promise in Endometrial Cancer Trial
Trendline Trendline
FDA Alignment and AI Integration Crucial for Rare Disease Treatment Advancements

FDA Alignment and AI Integration Crucial for Rare Disease Treatment Advancements

FDA Alignment and AI Integration Crucial for Rare Disease Treatment Advancements
Trendline Trendline
Sensei Biotherapeutics Advances Cancer Treatment with PIKTOR Amid Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment with PIKTOR Amid Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment with PIKTOR Amid Financial Growth